Skip to main content
72°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tela Bio Inc
(NQ:
TELA
)
4.700
-0.440 (-8.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tela Bio Inc
< Previous
1
2
3
4
Next >
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Jefferies Global Healthcare Conference
May 25, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Recap: TELA Bio Q1 Earnings
May 11, 2023
Via
Benzinga
Why TELA Bio Stock Is Dropping Today
April 19, 2023
TELA Bio (NASDAQ: TELA) shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share.
Via
Benzinga
Preview: TELA Bio's Earnings
March 20, 2023
Via
Benzinga
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
May 19, 2023
Company prioritizes education with a variety of in-person and virtual training programs
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
May 09, 2023
Leader in innovative soft-tissue tissue reconstruction solutions sponsors event advocating for and mentoring women in surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the JMP Securities Life Sciences Conference
May 02, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce First Quarter 2023 Financial Results
April 27, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Pricing of Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Proposed Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
March 29, 2023
Presentations highlight utility of this advanced hernia reinforcement material for robotic procedures
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
March 23, 2023
Company continues design advancements of biologic-based materials for soft tissue repair and reinforcement
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2023
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
March 16, 2023
Recent research of OviTex® Reinforced Tissue Matrix demonstrated favorable results in various hernia and abdominal wall reconstruction applications
From
TELA Bio, Inc.
Via
GlobeNewswire
Elon Musk A Frequent Flier In 2022 With Flights Lasting As Little As 13 Minutes, Says Report: His Love For Jet-Setting At Odds With Tesla's Climate Stance?
March 06, 2023
Tesla Inc. (NASDAQ: TELA) CEO Elon Musk is an entrepreneur who has his fingers in many pies, and undoubtedly time is money for him.
Via
Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
February 21, 2023
Company continues to expand innovative product portfolio to address surgeon needs
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
February 14, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
January 09, 2023
Company grows product portfolio, expanding product offerings to optimize soft tissue preservation and restoration
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 09, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.